HRP20090264T1 - Derivati fenil-piperazin metanona - Google Patents
Derivati fenil-piperazin metanonaInfo
- Publication number
- HRP20090264T1 HRP20090264T1 HR20090264T HRP20090264T HRP20090264T1 HR P20090264 T1 HRP20090264 T1 HR P20090264T1 HR 20090264 T HR20090264 T HR 20090264T HR P20090264 T HRP20090264 T HR P20090264T HR P20090264 T1 HRP20090264 T1 HR P20090264T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- halogen
- piperazin
- phenyl
- methanone derivatives
- Prior art date
Links
- GVAZRXZHSAHAOE-UHFFFAOYSA-N formaldehyde;1-phenylpiperazine Chemical class O=C.C1CNCCN1C1=CC=CC=C1 GVAZRXZHSAHAOE-UHFFFAOYSA-N 0.000 title 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Spojevi opće formule,naznačeni time, da je R1 skupinaR2 je nearomatski heterocikl, termin "nearomatski heterocikl" označava heterociklički prsten s pet ili šest članova koji sadrži jedan ili dva heteroatoma, izabranih iz skupine koja se sastoji od O, N ili S ili je OR' ili N(R")2;R' je C1-C7 alkil, C1-C7 alkil supstituiran halogenom ili -(CH2)n-Cikloalkil; R" je C1-C7 alkil; R3 je NO2, CN ili SO2R'; R4 je vodik, hidroksi, halogen, NO2, C1-C7 alkil, C1-C7 alkil supstituiran halogenom, C1-C7 alkoksi, SO2R' ili C(O)OR";R5/R6/R7 su vodik, halogen, C1-C7 alkil ili C1-C7 alkil supstituiran halogenom; X1/X1' su CH ili N, uz uvjet da X1/X1' nisu istodobno CH; X2 je O, S, NH ili N(C1-C7 alkil); n je 0, 1 ili 2; i farmaceutski aktivne soli uz dodatak kiseline. Patent sadrži 13 patentnih zahtjeva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106440 | 2004-12-09 | ||
PCT/EP2005/012833 WO2006061135A1 (en) | 2004-12-09 | 2005-12-01 | Phenyl-piperazin methanone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090264T1 true HRP20090264T1 (hr) | 2009-06-30 |
Family
ID=36061356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090264T HRP20090264T1 (hr) | 2004-12-09 | 2009-05-12 | Derivati fenil-piperazin metanona |
Country Status (27)
Country | Link |
---|---|
US (2) | US7241761B2 (hr) |
EP (1) | EP1828154B1 (hr) |
JP (1) | JP4762250B2 (hr) |
KR (1) | KR100880093B1 (hr) |
CN (1) | CN101072762B (hr) |
AR (1) | AR054102A1 (hr) |
AT (1) | ATE430142T1 (hr) |
AU (1) | AU2005313581B2 (hr) |
BR (1) | BRPI0518608A2 (hr) |
CA (1) | CA2589192C (hr) |
DE (1) | DE602005014274D1 (hr) |
DK (1) | DK1828154T3 (hr) |
ES (1) | ES2324232T3 (hr) |
HK (1) | HK1114841A1 (hr) |
HR (1) | HRP20090264T1 (hr) |
IL (1) | IL183594A (hr) |
MX (1) | MX2007006429A (hr) |
MY (1) | MY141969A (hr) |
NO (1) | NO20072643L (hr) |
NZ (1) | NZ555290A (hr) |
PL (1) | PL1828154T3 (hr) |
PT (1) | PT1828154E (hr) |
RU (1) | RU2395502C2 (hr) |
SI (1) | SI1828154T1 (hr) |
TW (1) | TWI304064B (hr) |
WO (1) | WO2006061135A1 (hr) |
ZA (1) | ZA200705027B (hr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7485637B2 (en) * | 2005-01-04 | 2009-02-03 | Hoffmann-La Roche Inc. | Benzoyl-tetrahydropiperidine derivatives |
EP2131843B1 (en) * | 2007-03-05 | 2011-11-09 | F. Hoffmann-La Roche AG | Process for the synthesis of glyt-1 inhibitors |
NZ604035A (en) * | 2010-06-04 | 2015-02-27 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
WO2011163636A2 (en) * | 2010-06-24 | 2011-12-29 | The Regents Of The University Of California | Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
FR2967674B1 (fr) * | 2010-11-23 | 2012-12-14 | Pf Medicament | Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine |
RU2496495C2 (ru) * | 2011-12-05 | 2013-10-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт нормальной физиологии имени П.К. Анохина РАМН | ПРИМЕНЕНИЕ СЕЛЕКТИВНОГО АНТАГОНИСТА ГЛУТАМАТНЫХ РЕЦЕПТОРОВ Ro-256981 ДЛЯ НАПРАВЛЕННОГО ВЛИЯНИЯ НА КОГНИТИВНЫЕ ФУНКЦИИ |
EP2968296B1 (en) | 2013-03-12 | 2020-09-02 | The Regents of the University of California | Gamma-secretase modulators |
AU2015338946B2 (en) | 2014-10-31 | 2020-06-11 | The General Hospital Corporation | Potent gamma-secretase modulators |
CN105712945B (zh) * | 2014-12-22 | 2020-12-01 | 上海翰森生物医药科技有限公司 | 2-取代氧基-5-甲砜基芳基哌嗪酰胺类似物及其制备方法和用途 |
CN105712952B (zh) * | 2014-12-22 | 2021-03-26 | 上海翰森生物医药科技有限公司 | 2-取代氧基-5-甲砜基苯基哌嗪酰胺类似物及其制备方法和用途 |
JP6985296B2 (ja) * | 2016-05-17 | 2021-12-22 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | ピペラジニルメタノンnaaa阻害剤 |
CN111116573B (zh) * | 2019-12-31 | 2021-08-06 | 中山大学 | 一种双通道下同时检测dna和rna的近红外荧光探针及其制备方法和应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2423847A1 (de) * | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
DE2611705A1 (de) * | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
IT1176613B (it) | 1984-08-14 | 1987-08-18 | Ravizza Spa | Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione |
RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
SK13092000A3 (sk) | 1998-03-06 | 2001-03-12 | Janssen Pharmaceutica N. V. | Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie |
BR9907951A (pt) * | 1998-03-06 | 2001-01-30 | Janssen Pharmaceutica Nv | Inibidores de transporte de glicina |
EP1296950A2 (en) * | 2000-04-20 | 2003-04-02 | NPS Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
GB0021419D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
US20020082283A1 (en) * | 2000-09-14 | 2002-06-27 | Gliatech, Inc. | Nitrogen-containing compounds and their use as glycine transport inhibitors |
JP2005502623A (ja) | 2001-07-02 | 2005-01-27 | ノボ ノルディスク アクティーゼルスカブ | 置換ピペラジンおよびジアゼパン |
US7126027B2 (en) | 2001-07-17 | 2006-10-24 | Akzo Nobel N.V. | N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
WO2003035602A1 (fr) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Modulateurs lipidiques |
US6916804B2 (en) * | 2001-12-20 | 2005-07-12 | Osi Pharmaceuticals, Inc. | Pyrimidine A2b selective antagonist compounds, their synthesis and use |
US20060052597A1 (en) | 2002-10-22 | 2006-03-09 | Best Desmond J | Aryloxyalkylamine derivatives as h3 receptor ligands |
DK1594840T3 (da) * | 2003-02-17 | 2007-02-05 | Hoffmann La Roche | Piperidin-benzensulfonamid-derivater |
GB0314476D0 (en) | 2003-06-20 | 2003-07-23 | Glaxo Group Ltd | Compounds |
GB0314479D0 (en) * | 2003-06-20 | 2003-07-23 | Glaxo Group Ltd | Compounds |
WO2005014563A1 (en) * | 2003-08-11 | 2005-02-17 | F. Hoffmann-La Roche Ag | Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
AU2004269892B2 (en) * | 2003-09-09 | 2010-03-11 | F. Hoffmann-La Roche Ag | 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
WO2005023260A1 (en) * | 2003-09-09 | 2005-03-17 | F. Hoffmann-La Roche Ag | 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
FR2861073B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
GB0408777D0 (en) | 2004-04-20 | 2004-05-26 | Glaxo Group Ltd | Compounds |
CA2564501A1 (en) * | 2004-04-29 | 2005-11-24 | Merck Sharp & Dohme Limited | Azetidine glycine transporter inhibitors |
GB0505086D0 (en) * | 2005-03-11 | 2005-04-20 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-12-01 RU RU2007120209/04A patent/RU2395502C2/ru not_active IP Right Cessation
- 2005-12-01 NZ NZ555290A patent/NZ555290A/en not_active IP Right Cessation
- 2005-12-01 DK DK05817965T patent/DK1828154T3/da active
- 2005-12-01 EP EP05817965A patent/EP1828154B1/en active Active
- 2005-12-01 DE DE602005014274T patent/DE602005014274D1/de active Active
- 2005-12-01 PT PT05817965T patent/PT1828154E/pt unknown
- 2005-12-01 SI SI200530699T patent/SI1828154T1/sl unknown
- 2005-12-01 CA CA2589192A patent/CA2589192C/en not_active Expired - Fee Related
- 2005-12-01 AU AU2005313581A patent/AU2005313581B2/en not_active Ceased
- 2005-12-01 BR BRPI0518608-0A patent/BRPI0518608A2/pt active Search and Examination
- 2005-12-01 US US11/291,216 patent/US7241761B2/en not_active Expired - Fee Related
- 2005-12-01 AT AT05817965T patent/ATE430142T1/de active
- 2005-12-01 KR KR1020077015528A patent/KR100880093B1/ko not_active IP Right Cessation
- 2005-12-01 MX MX2007006429A patent/MX2007006429A/es active IP Right Grant
- 2005-12-01 CN CN2005800421620A patent/CN101072762B/zh not_active Expired - Fee Related
- 2005-12-01 WO PCT/EP2005/012833 patent/WO2006061135A1/en active Application Filing
- 2005-12-01 ES ES05817965T patent/ES2324232T3/es active Active
- 2005-12-01 PL PL05817965T patent/PL1828154T3/pl unknown
- 2005-12-01 JP JP2007544778A patent/JP4762250B2/ja not_active Expired - Fee Related
- 2005-12-06 TW TW094143004A patent/TWI304064B/zh not_active IP Right Cessation
- 2005-12-07 AR ARP050105107A patent/AR054102A1/es not_active Application Discontinuation
- 2005-12-07 MY MYPI20055721A patent/MY141969A/en unknown
-
2007
- 2007-05-21 US US11/804,955 patent/US7429585B2/en not_active Expired - Fee Related
- 2007-05-24 NO NO20072643A patent/NO20072643L/no not_active Application Discontinuation
- 2007-05-31 IL IL183594A patent/IL183594A/en not_active IP Right Cessation
- 2007-06-04 ZA ZA200705027A patent/ZA200705027B/xx unknown
-
2008
- 2008-04-29 HK HK08104729.2A patent/HK1114841A1/xx not_active IP Right Cessation
-
2009
- 2009-05-12 HR HR20090264T patent/HRP20090264T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090264T1 (hr) | Derivati fenil-piperazin metanona | |
PE20090276A1 (es) | Compuestos derivados de imidazoquinolina como moduladores de tlr7 | |
ECSP066967A (es) | Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos | |
HRP20070510T3 (hr) | Derivati benzimidazola i njihova upotreba kao antagonista ii receptora | |
AR057894A1 (es) | Derivados de tiofeno | |
DE60140456D1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
EA200600925A1 (ru) | Производные триазола в качестве антагонистов вазопрессина | |
PE20061124A1 (es) | Compuestos y derivados de dibencil amina | |
ME00411B (me) | Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma | |
DE602005023015D1 (de) | Indolderivate als viruzide | |
TNSN01011A1 (en) | 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS | |
HRP20090162T1 (hr) | Kinolinon-karboksamidni spojevi kao agonisti 5-ht4 receptora | |
HRP20080429T3 (hr) | Disupstituirani pirazolobenzodiazepini korisni kao inhibitori za cdk2 i angiogenezu i za liječenje raka dojke, debelog crijeva, pluća i prostate | |
AR047817A1 (es) | Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica | |
AR025975A1 (es) | Compuestos quimicos. | |
PE20000263A1 (es) | Derivados ciclicos n-acilo de amina | |
PE20020566A1 (es) | DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA | |
AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
PE20070212A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
HRP20070286T3 (hr) | Supstituirani diketopiperazini i njihova upotrebakao oksitocinski antagonisti | |
SE0101579D0 (sv) | New compounds | |
ATE271868T1 (de) | Neue cathechole als antimikrobielle mittel | |
NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
EA200970497A1 (ru) | Производные пиррола, их получение и их применение в терапии |